433 related articles for article (PubMed ID: 18983607)
1. Salivary duct carcinoma in situ of the parotid gland.
Simpson RH; Desai S; Di Palma S
Histopathology; 2008 Oct; 53(4):416-25. PubMed ID: 18983607
[TBL] [Abstract][Full Text] [Related]
2. Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland.
Yamamoto H; Uryu H; Segawa Y; Tsuneyoshi M
Pathol Int; 2008 May; 58(5):322-6. PubMed ID: 18429833
[TBL] [Abstract][Full Text] [Related]
3. Low grade salivary duct carcinoma. A distinctive variant with a low grade histology and a predominant intraductal growth pattern.
Delgado R; Klimstra D; Albores-Saavedra J
Cancer; 1996 Sep; 78(5):958-67. PubMed ID: 8780532
[TBL] [Abstract][Full Text] [Related]
4. Hybrid carcinoma of the parotid gland: report of a case (epithelial-myoepithelial carcinoma and salivary duct carcinoma) and review of the literature.
Kainuma K; Oshima A; Suzuki H; Fukushima M; Shimojo H; Usami S
Acta Otolaryngol; 2010; 130(1):185-9. PubMed ID: 19449226
[TBL] [Abstract][Full Text] [Related]
5. Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland.
Cornolti G; Ungari M; Morassi ML; Facchetti F; Rossi E; Lombardi D; Nicolai P
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1031-6. PubMed ID: 17938328
[TBL] [Abstract][Full Text] [Related]
6. Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
Clauditz TS; Reiff M; Gravert L; Gnoss A; Tsourlakis MC; Münscher A; Sauter G; Bokemeyer C; Knecht R; Wilczak W
Pathology; 2011 Aug; 43(5):459-64. PubMed ID: 21670724
[TBL] [Abstract][Full Text] [Related]
7. Salivary duct carcinoma--a highly aggressive salivary gland tumour with overexpression of c-erbB-2.
Hellquist HB; Karlsson MG; Nilsson C
J Pathol; 1994 Jan; 172(1):35-44. PubMed ID: 7931825
[TBL] [Abstract][Full Text] [Related]
8. Low-grade cribriform cystadenocarcinoma of the parotid gland: a neoplasm with favorable prognosis, distinct from salivary duct carcinoma.
Laco J; Podhola M; Dolezalova H
Int J Surg Pathol; 2010 Oct; 18(5):369-73. PubMed ID: 21068068
[TBL] [Abstract][Full Text] [Related]
9. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.
Di Palma S; Simpson RH; Marchiò C; Skálová A; Ungari M; Sandison A; Whitaker S; Parry S; Reis-Filho JS
Histopathology; 2012 Oct; 61(4):629-43. PubMed ID: 22882517
[TBL] [Abstract][Full Text] [Related]
10. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry.
Skálová A; Stárek I; Vanecek T; Kucerová V; Plank L; Szépe P; Di Palma S; Leivo I
Histopathology; 2003 Apr; 42(4):348-56. PubMed ID: 12653946
[TBL] [Abstract][Full Text] [Related]
11. Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma.
Kapadia SB; Barnes L
Mod Pathol; 1998 Nov; 11(11):1033-8. PubMed ID: 9831198
[TBL] [Abstract][Full Text] [Related]
12. [Salivary duct carcinomas comprise phenotypically and genotypically diverse high grade neoplasms].
Hungermann D; Korsching E; Bürger H; Röser K; Löning T; Herbst H
Verh Dtsch Ges Pathol; 2006; 90():168-76. PubMed ID: 17867594
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
Williams MD; Roberts D; Blumenschein GR; Temam S; Kies MS; Rosenthal DI; Weber RS; El-Naggar AK
Am J Surg Pathol; 2007 Nov; 31(11):1645-52. PubMed ID: 18059220
[TBL] [Abstract][Full Text] [Related]
14. [About the prognostic value of Her-2 gene-amplification and cell-proliferation in salivary duct carcinoma of the major salivary glands - a pilot-study].
Jaehne M; Jäkel KT; Röser K; Ussmüller J; Löning T
Laryngorhinootologie; 2001 Sep; 80(9):525-9. PubMed ID: 11555785
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
[TBL] [Abstract][Full Text] [Related]
16. Intraductal carcinoma of salivary gland (so-called low-grade cribriform cystadenocarcinoma) arising in an intraparotid lymph node.
Weinreb I
Head Neck Pathol; 2011 Sep; 5(3):321-5. PubMed ID: 21442195
[TBL] [Abstract][Full Text] [Related]
17. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.
Bahrami A; Perez-Ordonez B; Dalton JD; Weinreb I
Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717
[TBL] [Abstract][Full Text] [Related]
18. [Salivary duct cyst of the parotid gland and adenocarcinoma].
Schwetschke O; Zimmerer A; Bosch FX; Maier H
HNO; 1994 Jul; 42(7):441-5. PubMed ID: 7928436
[TBL] [Abstract][Full Text] [Related]
19. Epithelial myoepithelial carcinoma of the parotid gland.
Morrow TA; Chun T; Mirani N
Ear Nose Throat J; 1990 Sep; 69(9):646-8. PubMed ID: 2245792
[TBL] [Abstract][Full Text] [Related]
20. Salivary duct carcinoma of the parotid gland presenting KIT (CD117) overexpression.
Sato K; Shimode Y; Itoi A; Ueda Y; Katsuda S
Histopathology; 2007 Jul; 51(1):114-5. PubMed ID: 17532773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
